DARE insider filings
Dare Bioscience, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-20. Screen DARE transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing by 1 insider — 859 shares, $382 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: sale of 859 shares @ $0.45 ($382) by RASTETTER WILLIAM H, filed 2026-11-20.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| RASTETTER WILLIAM H — Director | 1 | — | 1 leg · 859 sh · $382 | — |
Recent insider filings — Dare Bioscience, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-20 | 4 | RASTETTER WILLIAM H — Director | Sale (S): 859 @ $0.45 | EDGAR |
| 2026-07-02 | 4 | Grossman Jessica D. — Director | Grant/award (A): 26,066 @ $0 | EDGAR |
| 2026-07-02 | 4 | Kelley Susan L. — Director | Grant/award (A): 23,696 @ $0 | EDGAR |
| 2026-07-02 | 4 | Matz Gregory W — Director | Grant/award (A): 30,805 @ $0 | EDGAR |
| 2026-07-02 | 4 | Steele Robin Joan — Director | Grant/award (A): 26,540 @ $0 | EDGAR |
| 2026-07-02 | 4 | RASTETTER WILLIAM H — Director | Grant/award (A): 38,862 @ $0 | EDGAR |
| 2026-06-11 | 4 | Grossman Jessica D. — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Matz Gregory W — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Kelley Susan L. — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Steele Robin Joan — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | RASTETTER WILLIAM H — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | JOHNSON SABRINA MARTUCCI — Chef Executive Officer, Director | Grant/award (A): 10,800 (derivative) · Grant/award (A): 21,600 (derivative) | EDGAR |
| 2026-02-02 | 4 | Haring-Layton MarDee — Chief Accounting Officer | Grant/award (A): 49,000 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | JOHNSON SABRINA MARTUCCI — Chef Executive Officer, Director | Grant/award (A): 172,000 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | Haring-Layton MarDee — Chief Accounting Officer | Grant/award (A): 57,000 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Matz Gregory W — Director | Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Grossman Jessica D. — Director | Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Kelley Susan L. — Director | Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Steele Robin Joan — Director | Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | RASTETTER WILLIAM H — Director | Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Haring-Layton MarDee — Chief Accounting Officer | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | JOHNSON SABRINA MARTUCCI — Chef Executive Officer, Director | Grant/award (A): 107,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Grossman Jessica D. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Kelley Susan L. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Matz Gregory W — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Steele Robin Joan — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | RASTETTER WILLIAM H — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-03-14 | 4 | Fair John A — Chief Commercial Officer | Grant/award (A): 290,000 (derivative) @ $0 | EDGAR |
| 2024-03-14 | 4 | Haring-Layton MarDee — Chief Accounting Officer | Grant/award (A): 290,000 (derivative) @ $0 | EDGAR |
| 2024-03-14 | 4 | JOHNSON SABRINA MARTUCCI — Chef Executive Officer, Director | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Grossman Jessica D. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Ononye-Onyia Sophia Nnenna — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Kelley Susan L. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Matz Gregory W — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Blanchard Cheryl R — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Steele Robin Joan — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | RASTETTER WILLIAM H — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-01-26 | 4 | Walters-Hoffert Lisa — Chief Financial Officer | Grant/award (A): 290,000 (derivative) @ $0 | EDGAR |
| 2023-01-26 | 4 | Fair John A — Chief Commercial Officer | Grant/award (A): 290,000 (derivative) @ $0 | EDGAR |
| 2023-01-26 | 4 | JOHNSON SABRINA MARTUCCI — Chef Executive Officer, Director | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Matz Gregory W — Director | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Ononye-Onyia Sophia Nnenna — Director | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Grossman Jessica D. — Director | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Kelley Susan L. — Director | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Blanchard Cheryl R — Director | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Steele Robin Joan — Director | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | RASTETTER WILLIAM H — Director | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2022-01-28 | 4 | Fair John A — Chief Strategy Officer | Grant/award (A): 185,000 (derivative) @ $0 | EDGAR |
| 2022-01-28 | 4 | Walters-Hoffert Lisa — Chief Financial Officer | Grant/award (A): 185,000 (derivative) @ $0 | EDGAR |
| 2022-01-28 | 4 | JOHNSON SABRINA MARTUCCI — Chef Executive Officer, Director | Grant/award (A): 628,400 (derivative) @ $0 | EDGAR |
Recent 8-K events — Dare Bioscience, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-10-02 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-10-01 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-11 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | EDGAR |
| 2026-09-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-24 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Registration filings — Dare Bioscience, Inc.
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-298585 (S-1) — latest: Initial registration (S-1), filed 2026-08-26
GET https://api.filingpulse.io/v1/insider-trades?ticker=DARE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs